Search
New treatments offer hope for childhood cancer patients
- OPACC
- Oct 15, 2024
- 1 min read
Although the prognosis for most patients with pediatric cancer is good, one of the differences in treatment between childhood and adult cancer patients is the lack of new drugs being approved by the Federal Drug Administration (FDA) for use on children.
Recent Posts
See AllThe FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type...
Untreated growth hormone deficiency was associated with neurocognitive impairment and reduced physical functioning among adult survivors...
A Phase I clinical trial demonstrated that a targeted approach to treating a deadly brain tumor in children called diffuse intrinsic...
Comments